Update: Beta Bionics, Senseonics to Integrate Diabetes Devices; Shares Rise

03:06 PM EDT, 09/22/2026 (MT Newswires) -- (Updates with the latest stock price in the headline and last paragraph.) Beta Bionics (BBNX) reported Tuesday a partnership to integrate its iLet Bionic Pancreas and mint automated insulin delivery systems with Senseonics' (SENS) Eversense 365 continuous glucose monitoring system. The company said it expects to launch the integrated iLet and Eversense 365 system commercially in Q4. Beta Bionics said the integration will give iLet users access to more continuous glucose monitoring options. The companies also plan to integrate the mint system with Eversense 365 in the future, the company added. Shares of Beta Bionics were up over 4% in afternoon trading, while Senseonics stock was up more than 1%. Price: 22.98, Change: +0.94, Percent Change: +4.26